Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 76 AL 90

The Importance of Understanding Amylin Signaling Mechanisms for Therapeutic Development in the Treatment of Alzheimer's Disease

Servizi S, Corrigan RR, Casadesus G.

Curr Pharm Des. 2020;26(12):1345-1355. doi: 10.2174/1381612826666200318151146.

Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer's Disease

Gião T, Saavedra J, Cotrina E, Quintana J, Llop J, Arsequell G, Cardoso I.

Int J Mol Sci. 2020 Mar 18;21(6):2075. doi: 10.3390/ijms21062075.

Synchronous measuring of triptolide changes in rat brain and blood and its application to a comparative pharmacokinetic study in normal and Alzheimer's disease rats

Zhu S, Wang X, Zheng Z, Zhao XE, Bai Y, Liu H.

J Pharm Biomed Anal. 2020 Jun 5;185:113263. doi: 10.1016/j.jpba.2020.113263. Epub 2020 Mar 17.

Intranasal Lipid Particulate Drug Delivery Systems: An Update on Clinical Challenges and Biodistribution Studies of Cerebroactive Drugs in Alzheimer's disease

Arora D, Bhatt S, Kumar M, Vattikonda HDC, Taneja Y, Jain V, Joshi V, Gali CC.

Curr Pharm Des. 2020;26(27):3281-3299. doi: 10.2174/1381612826666200331085854.

Editorial: Alzheimer's Disease Drug Development Pipeline 2020

Sabbagh MN.

J Prev Alzheimers Dis. 2020;7(2):66-67. doi: 10.14283/jpad.2020.12.

Gut Microbiota, Its Role in Induction of Alzheimer's Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins

Khan MS, Ikram M, Park JS, Park TJ, Kim MO.

Cells. 2020 Apr 1;9(4):853. doi: 10.3390/cells9040853.

γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase

Nie P, Vartak A, Li YM.

Semin Cell Dev Biol. 2020 Sep;105:43-53. doi: 10.1016/j.semcdb.2020.03.002. Epub 2020 Apr 2.

[Effect of electroacupuncture at governor vessel on learning-memory ability and serum level of APP, Aβ(1-42) in patients with Alzheimer's disease]

Xia KP, Pang J, Li SL, Zhang M, Li HL, Wang YJ.

Zhongguo Zhen Jiu. 2020 Apr 12;40(4):375-8. doi: 10.13703/j.0255-2930.20190728-0003.

Antagonism of cysteinyl leukotrienes and their receptors as a neuroinflammatory target in Alzheimer's disease

Singh RK.

Neurol Sci. 2020 Aug;41(8):2081-2093. doi: 10.1007/s10072-020-04369-7. Epub 2020 Apr 13.

Microbial acetylcholinesterase inhibitors for Alzheimer's therapy: recent trends on extraction, detection, irradiation-assisted production improvement and nano-structured drug delivery

Zaki AG, El-Sayed ER, Abd Elkodous M, El-Sayyad GS.

Appl Microbiol Biotechnol. 2020 Jun;104(11):4717-4735. doi: 10.1007/s00253-020-10560-9. Epub 2020 Apr 13.

Tau Protein Aggregation in Alzheimer's Disease: Recent Advances in the Development of Novel Therapeutic Agents

Monteiro KLC, Alcântara MGDS, de Aquino TM, da Silva-Júnior EF.

Curr Pharm Des. 2020;26(15):1682-1692. doi: 10.2174/1381612826666200414164038.

Alzheimer Drug Trials: Combination of Safe and Efficacious Biologicals to Break the Amyloidosis-Neuroinflammation Vicious Cycle

Bartfai T, Lees GV.

ASN Neuro. 2020 Jan-Dec;12:1759091420918557. doi: 10.1177/1759091420918557.

Recent Studies on Design and Development of Drugs Against Alzheimer's Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents

Gupta SP, Patil VM.

Curr Top Med Chem. 2020;20(13):1195-1213. doi: 10.2174/1568026620666200416091623.

The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use

Shukla M, Vincent B.

Ageing Res Rev. 2020 Jul;60:101062. doi: 10.1016/j.arr.2020.101062. Epub 2020 Apr 15.

Mechanisms of Electroacupuncture on Alzheimer's Disease: A Review of Animal Studies

Song YY, Xu WT, Zhang XC, Ni GX.

Chin J Integr Med. 2020 Jun;26(6):473-480. doi: 10.1007/s11655-020-3092-9. Epub 2020 Apr 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias